Polyketides are a unique class of molecules with attractive bioactive and chemical properties. As a result, biorenewable production is being explored with these molecules as potential pharmaceutical, fuel, and material precursors. In particular, type III polyketide synthases enable access to a diverse class of chemicals using a relatively simple biochemical synthesis pathway. In this review, the recent advances in the engineering of microbial hosts for the production of type III PKS-derived polyketides are highlighted. In particular, the field has moved beyond simple proof-of-concept and has been exploring engineering efforts that have led to improved production scales. This review details engineering progress for the production of acetyl-CoA-and malonyl-CoA-derived polyketides including the products triacetic acid lactone and phloroglucinol as well as polyphenolic, phenylpropanoidderived compounds including flavonoids, stilbenoids, and curcuminoids. Specifically, the authors focus on enumerating the metabolic engineering strategies employed and product titers achieved for these molecules. Finally, the authors highlight tools and strategies that can be leveraged to realize the potential of microbial production and diversification of these molecules.
Introduction
Polyketides are an extremely diverse class of secondary metabolites natively produced by a host of microbial organisms and plants and employed for a variety of purposes including defense, pigmentation, and communication. [1] [2] [3] On a biochemical basis, polyketides are formed by polyketide synthases (PKSs) that catalyze the iterative condensation of CoA precursors into a polyketide chain, which is then cyclized. [1] [2] [3] However, these PKSs vary greatly in structure and are typically classified as one of three different types. Type I and type II PKSs comprise large protein assemblies with many specialized subunits. [1, 4, 5] In contrast, type III PKSs are small, homodimeric enzymes with active sites that perform both chain extension and cyclization. [6] [7] [8] While initially thought to be plant-specific, type III PKS genes have been identified in a wide range of life including bacteria and fungi. Type III PKS-derived polyketides have the potential to serve a variety of purposes, including as pharmaceuticals or nutraceuticals due to bioactive properties and as pigments and plastic/fuel precursors due to their chemical traits.
Polyketide synthesis requires two major metabolite elements: the starter CoA molecule that initiates the formation of the polyketide chain and the extender unit, which is condensed onto the growing chain. [6] [7] [8] The vast majority of type III PKSs use malonyl-CoA as the extender unit, but vary greatly in their use of starter CoAs, thus contributing to the diversity of downstream compounds. As examples, some PKSs use small acyl-CoAs, such as acetyl-CoA and malonyl-CoA whereas others, especially those derived from plants, use larger phenylpropanoid CoA molecules such as 4-coumaroyl-CoA. [6] [7] [8] As a result, the simplicity of type III PKS activity, linked with the diverse cadre of potential downstream molecules has spurred interest in heterologous, microbial production. In recent years, there has been tremendous progress toward producing these molecules in microbes, moving from proof-of-concept production to tens of grams per liter. Therefore, this review aims to present current trends and successes in the area of type III PKS-derived polyketide synthesis along with the metabolic engineering feats required to rewire production hosts. In doing so, we first highlight and compare the most common microbial hosts explored for this production. Second, we explore advances in the production of both acetyl-CoA-and malonyl-CoA-derived polyketides and polyphenols. Third, we summarize emerging tools and computational approaches that can advance the field of microbial production of polyketides. Throughout this review, we focus on enumerating the metabolic engineering strategies employed and product titers achieved for these molecules.
challenges with respect to expression, production, genetic tractability, and precursor availability. We first describe in this section the advantages, challenges, and efforts in each of these hosts before turning to specific polyketide production in subsequent sections of this review. Figure 1 summarizes the host organisms described herein.
Escherichia coli
As a mainstream host for metabolic engineering, [9] Escherichia coli possesses several advantages with regards to polyketide production. Of highest interest, this host is the most genetically tractable and thus allows for the rapid testing of constructs and use of bacterially derived biosensors for strain optimization. Yet, one major drawback of E. coli as a host is limited metabolic flux toward the key polyketide extender molecule, malonyl-CoA. To this end, researchers have employed different strategies to overcome this limitation in an effort to boost polyketide production. As an example, research has focused on improving the acetyl-CoA carboxylase (ACC) reaction that fuels malonyl-CoA production by expressing the two subunits of the Corynebacterium glutamicum ACC. This approach has been used for several polyketide production studies in E. coli. [10] [11] [12] Another common target for overexpression is the native acetyl-CoA synthetase (ACS), which serves to further promote malonyl-CoA production. [12, 13] Additional native gene manipulations have included deletion of genes associated with byproduct formation [12] and modification of targets seeking to improve NADPH availability, [14] as well as targets derived from metabolic modeling. [15] As an alternative anabolic pathway into malonyl-CoA, the malonate pathway can be synthetically imported into E. coli, as demonstrated by heterologous expression of the matB and matC genes from Rhizobium trifolii. [16] [17] [18] In this scheme, cells are fed malonate, which is imported by matC and converted to malonyl-CoA by matB. Finally, a variety of malonyl-CoA sensors have been used for both directed evolution and target identification to increase metabolite supply. [19] [20] [21] A collection of past research in de-bottlenecking the aromatic amino acid pathway in E. coli [22, 23] has aided the production of phenylpropanoid-derived polyketides. Specifically, E. coli strains optimized for tyrosine production typically involve overexpression of native tyrosine biosynthesis genes and feedback resistant versions of the 3-deoxy-D-arabinoheptulosonate-7-phosphate (DAHP) synthase and chorismate mutase genes. [24] [25] [26] [27] [28] [29] [30] [31] [32] Key deletion targets include the regulatory protein TyrA and genes that encode branch-point diversions into tryptophan (trpED) [25, 32, 33] or phenylalanine (pheA). [30] This background strain can be further engineered to produce the desired phenylpropanoid CoA esters (such as 4-coumaroyl-CoA) to convert into polyketides. [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] A graphical summary of the major pathways targeted in all of these engineering strategies is provided in Figure 2 .
Saccharomyces cerevisiae
Like E. coli, Saccharomyces cerevisiae is commonly studied for type III PKS-derived polyketide production, as it is a well-characterized host with a wide variety of tools. [38, 39] Similar strategies to those described for E. coli have been employed in S. cerevisiae to increase malonyl-CoA production, including native ACC overexpression, [40] knockouts of competing reactions, [41] cofactor optimization, [42] as well as the use of malonyl-CoA sensors for dynamic pathway control. [43, 44] To enable polyphenol production, researchers typically modify aromatic amino acid metabolism, www.advancedsciencenews.com www.biotechnology-journal.com as these chemicals are needed to produce starter CoA units. In particular, the Ehrlich pathway, which degrades the phenylalanine precursor phenylpyruvate, has been targeted for gene deletion, improving polyphenol production. [34] In parallel to the efforts in E. coli, feedback-resistant mutants of the DAHP synthase and chorismate mutase have been explored to promote tyrosine production. [35] [36] [37] In contrast to E. coli, S. cerevisiae has particular advantages for the production of plant secondary metabolites, especially with the higher expression success rates of cytochrome P450 enzymes necessary for downstream tailoring of polyketide scaffolds. As a result, this host is explored when more complex biochemistry is utilized.
Streptomyces venezuelae
Streptomyces venezualae is a commonly used host for complex polyketide production, especially for type I and II PKS systems. [45] However, for the case of type III PKS-derived products, production in this organism has been quite limited with titers in the low mg L À1 scale. [46] [47] [48] One of the main advantages of a host like S. venezualae is its evolutionary similarity to species that produce complex polyketides. However, this is not necessarily the case for many type III PKSs. Furthermore, the capacity and advantage of S. venezualae to express large biosynthetic gene clusters is not necessary with the genetically simpler type III PKSs. Therefore, while S. venezualae is a premier host for the expression of many PKS systems, it is not necessarily a highly used host for the production of type III PKS-derived polyketides.
Corynebacterium glutamicum
Corynebacterium glutamicum is a valuable production host commonly used for the industrial production of amino acids. [49] Of relevance to polyketide production, this host has strong resistance to aromatic compounds. For these reasons, C. glutamicum has been investigated for production of polyphenolic type III PKS-derived polyketides. However, this innate resistance to aromatic compounds is related to robust pathways for the degradation of aromatic compounds. Therefore, in order to optimize this host for production, researchers deleted four major aromatic catabolic gene clusters creating the strain DelAro 4 . [50] This resulting strain was then used as the starting point for future polyketide studies in C. glutamicum. [51] [52] [53] 
Yarrowia lipolytica
A recently proposed host for polyketide production is the oleaginous yeast Yarrowia lipolytica owing to the high acetyl-CoA and malonyl-CoA pools implicit in this organism as an industrial workhorse for lipid and organic acid production. [54] It was recently shown that this high flux through acyl-CoA precursors could be diverted away from lipid production and into production of the polyketide, triacetic acid lactone. [55, 56] While no other type III PKS-derived polyketides have yet been produced by Y. lipolytica, the extraordinarily high titer achieved in this rewired strain holds promise as an exciting starting point for expanding the reach of this organism as a type III PKSderived polyketide host. [55] 
Acetyl and Malonyl-CoA Derived Polyketides
Next, we turn to discussing advances in specific polyketide production. While the vast majority of characterized type III PKSs are of the class that use phenylpropanoid-derived starter CoA esters (see Section 4 of this review), there are several simpler systems that only use acetyl-CoA or malonyl-CoA as starters. As these starter blocks are central metabolites produced natively by microbial host systems, this initial class of polyketides can be made in heterologous hosts without the additional importation of upstream precursor pathways Figure 2 . An overview of precursor production pathways. Reactions targeted for engineering are shown in blue. Heterologous reactions are shown in green. A) Pathways for improved malonyl-CoA production. [76] B) Pathways for 4-coumaroyl-CoA production. [35] www.advancedsciencenews.com www.biotechnology-journal.com ( Figure 3 ). We describe advances in the production of three such polyketides here.
Triacetic Acid Lactone
Triacetic acid lactone is a simple polyketide produced through the condensation of two malonyl-CoA extender units with one acetyl-CoA precursor, and perhaps one of the better-explored type III PKS-derived polyketides to be produced in microbial hosts. This compound has been identified as a potential biorenewable platform chemical as it can be chemically converted into a variety of different valuable products traditionally sourced from petroleum, such as sorbic acid. [57] Additionally, triacetic acid lactone can be converted into antibiotics, such as pogostone, [58] as well as into novel polymers. [55] Biochemically, triacetic acid lactone is a common derailment product formed during the synthesis of other, longer polyketides. For this reason, early studies of triacetic acid lactone production used mutant versions of the type I PKS, 6methyl-salicylic acid synthase, and fatty acid synthase to produce this product. [59] Using this approach, researchers were able to produce 1.8 g L À1 of triacetic acid lactone following bioreactor fermentation using S. cerevisiae as a host. [59] However, a type III PKS from Gerbera hybrida was identified that natively produces triacetic acid lactone ( Figure 3a ). As a result, the 2-pyrone synthase (encoded by g2ps1) has been imported into E. coli, S. cerevisiae, and Y. lipolytica hosts and coupled with strain engineering. [41, 42, 55, 56, [59] [60] [61] Expression of this synthase in E. coli led to initial production of 0.5 g L À1 . [59] Additional improvements have been achieved through screening of a synthase mutant library as well as native E. coli overexpression and deletion libraries. [62, 63] Engineering in S. cerevisiae has employed overexpression of acetyl-CoA synthesis genes [42] together with rational engineering strategies including knockouts to decrease competing reactions such as gluconeogenesis and lipid biosynthesis, [41] as well as cofactor balancing and cytoplasmic localization of precursors. [42] These strategies were combined with an improved 2-PS mutant to produce 10.4 g L À1 in bioreactor fermentation. [60] A different strategy involved exploring industrial S. cerevisiae strains for high expression of g2ps1 to yield 5.2 g L À1 production in bioreactor fermentation. [61] The most successful strategy for triacetic acid lactone production deviated from traditional hosts and employed a precursor overexpression strategy in the nonconventional yeast, Y. lipolytica. By overexpression of the pyruvate bypass pathway combined with ACC, this strain was able to generate 35.9 g L À1 of triacetic acid lactone in bioreactor fermentation. [55] This result suggests that the oleaginous property of this yeast provides a more optimal starting point for acetyl-CoA-and malonyl-CoA-derived polyketides. Production levels and schemes for the engineering of triacetic acid lactone as well as the remaining polyketides discussed in this review are compared in Table 1 .
Phloroglucinol
Another long-explored type III PKS-derived polyketide, phloroglucinol, is a chemical scaffold of interest, leading to potential drug applications and valuable energetic compounds. [64, 65] A related chemical, 2,4-diacetylphloroglucinol, is produced natively in Pseudomonas fluorescens Pf-5 by the biosynthetic gene cluster, phlACBDE. [66] However, researchers found that when the type III PKS gene, phlD, is expressed alone in E. coli, phloroglucinol is directly produced from three malonyl-CoA units ( Figure 3b ). [67] One particular challenge limiting phlorglucinol production in E. coli is the toxicity of this product to the cell. Several strategies have been used to combat this toxicity including utilizing a stationary phase promoter for phlD, [68] overexpressing the native multiple resistance gene, [68] and employing a continuous product extraction scheme during fermentation. [69] The latter two strategies have been combined with ACC overexpression to produce 3.8 g L À1 and 3.7 g L À1 of phloroglucinol, respectively. [69, 70] Additionally, a mutant version of phlD for increased thermal stability was used in the final strategy. [69] 
Flaviolin
A final type III PKS enzyme that uses acyl-CoA precursors is the 1,3,6,8-tetrahydroxynaphthalene (THN) synthase, encoded by RppA and found natively in several Streptomyces species. This compound is a precursor in melanin synthesis and spontaneously oxidizes to flaviolin (Figure 3c ). [71] When RppA expression was combined with the malonyl-CoA enhancing overexpressions of ACC and two regulatory targets (metK1-sp and afsR-sp) in S. venezuelae, 12mgL À1 of flaviolin was detected in growth [80] Escherichia coli Flavonoid Sc4CL, GeCHS RrPAL Minimal, phe Flask 0.75 mg L À1 pinocembrin [27] Escherichia coli Flavonoid Pc4CL, GuCHS(S165M), MsCHI
CgACC, ACS, FabF, BoPAL Mineral Bioreactor 67.81 mg L À1 pinocembrin [28, 29] MsCHI RgPAL [92] Escherichia coli Flavonoid MdF3H, AaFLS, MdANS, Ph3GT
Minimal UDPglucose, flavanone Flask 5.6 μg L À1 pelargonidin-3glucoside and 6.0 μg L À1 cyanidin 3-Oglucoside [79] Saccharomyces cerevisiae Flavonoid At4CL, HaCHS RtPAL Complex Flask 7 mg L À1 naringenin, 0.8 mg L À1 pinocembrin, 9 mg L À1 phloretin, 11 mg L À1 trihydroxydihydrochalcone [37] Saccharomyces cerevisiae 
Saccharomyces cerevisiae
Flavonoid At4CL, AtCHS, AtCHI
Δaro3, ARO4(G226S) Δpdc6,
Δpdc5, Δaro10
Minimal Reactor 400 μM naringenin [114] Saccharomyces cerevisiae
Flavonoid

At4CL, HaCHS, PhCHO
Δpad1-fdc1Δaro10 Δtsc13::
MdECR, AtPAL, AtC4H
Minimal Deep well plates 200 mg L À1 naringenin [37] Saccharomyces cerevisiae Rich, acid Flask 415 μg L À1 apigenin,10 μg L À1 luteolin, 208 μg L À1 genkwanin [46] 
Streptomyces venezuelae
Flavonoid PcFSI native PKS deleted Complex, flavanone Flask 1.4 mg L À1 apigenin, 2.9 mg L À1 chrysin [90] Escherichia coli Flavonoid Pc4CL, PhCHS-AmCHR, MsCHI, AtF3H, AtFLS RsTAL Minimal Flask 0.3 mg L À1 fisetin [88] Escherichia coli Flavonoid Sc4CL, AtCHS SeTAL Minimal Flask 5.3 mg L À1 naringenin [14] Escherichia coli Flavonoid CsF3H, FaFLS, CsANS ΔpgiΔppc
Minimal, flavanone
Bioreactor 910.9 mg L À1 catechin [76, 115] Escherichia coli Flavonoid PhANS-At3GT pgm, galU, ndk,
ΔgalEΔgalT4udg
Minimal, flavanol, orotic acid Flask 104 mg L À1 cyanidin 3-Oglucoside, 113 mg L À1 pelargonidin 3-O-glucoside [93] Escherichia coli Flavonoid Pc4CLM PhCHS, MsCHI, AtF3H, Sa7OMT
NfACC, NfACS, NF biotin ligase Mineral, acid Flask 2.7 mg L À1 7-O-Methyl Aromadendrin [25] Escherichia coli Phenylpropanoid tyrR(fbr), aroG(fbr), SeTAL Minimal Flask 4-coumaric acid, caffeic acid, and ferulic acid reached 974 mg L À1 , 150 mg L À1 , and 196 mg L À1
[89]
Saccharomyces cerevisiae
Phenylpropanoid GmC4H, PtCPR, variable downstream PtPAL Defined, amino acid Flask 0.29 mg L À1 trans-resveratrol, 8.9 mg L À1 naringenin, 0.1 mg L À1 genistein, 0.9 mg L À1 kaempferol, 0.26 mg L À1 of quercetin [36] Saccharomyces cerevisiae Phenylpropanoid FjTAL, ARO4(K229L), ARO7 (G141S), EcaroL, Δpdc5 Δaro10
Minimal
Deep well plates 1.93 g L À1 4-coumaric acid [77, 101] Escherichia coli Stilbeniod Sc4CL, RpSTS, SbROMT
Rich, acid Flask resveratrol, pinostilbene, pterostilbene detection only [47] Streptomyces venezuelae medium. [48] Interestingly, when a putative set of RppA and cytochrome P450 genes were imported from Streptomyces olivaceus FXJ 7.023 into E. coli, the resulting strain was found to produce phenol and indole. [72] Following a continuous biosynthesis strategy whereby immobilized E. coli cells were used, final production of 0.67 g L À1 phenol and 14.5 g L À1 indole was achieved. [72] This exciting result suggests that further investigation into THN synthases could reveal interesting chemistry, thus further expanding the applications of polyketide production. [95] Escherichia coli Stilbeniod At4CL1, VvSTS Minimal, cerulenin, acid Flask 2.3 g L À1 resveratrol [18] Escherichia coli Stilbeniod Pc4CL, VvSTS matB, matC, RgTAL Minimal, tyr Flask 35 mg L À1 resveratrol [33] Escherichia coli Stilbeniod Pc4CL, VvSTS RgTAL, ΔtyrR ΔtrpED Complex Flask 4.612 mg L À1 resveratrol [30] Escherichia coli Stilbeniod strain 1: Pc4CL, VvSTS strain 2: RgTAL, aroG(fbr), tktA,
ΔpheA
Mineral, glycerol Flask 22.6 mg L À1 resveratrol [94] Saccharomyces cerevisiae
Stilbeniod
Nt4CL2, VvSTS Minimal, acid Flask 6 mg L À1 resveratrol [82] Saccharomyces cerevisiae
At4CL1-VvSTS Minimal, acid Flask 5.25 μg mL À1 resveratrol [98] Saccharomyces cerevisiae
At4CL1, VvSTS industrial Brazilian sugar cane-fermenting yeast
Rich, acid Flask 391 mg L À1 resveratrol [117] Saccharomyces cerevisiae
Stilbeniod
At4CL1-VvSTS RsTAL R. sphaeroides, EcaraE Defined, acid Flask 3.1 mg L À1 resveratrol [96] Saccharomyces cerevisiae Stilbeniod At4CL1, AhSTS Complex, acid Flask 3.1 mg L À1 resveratrol [40] Saccharomyces cerevisiae
AtC4H, At4CL, AhSTS RtPAL, ACC1 Complex Bioreactor 4.3 mg L À1 resveratrol [97] Saccharomyces cerevisiae Stilbeniod At4CL1-VvSTS AtMCS Defined, acid sup Flask 4 mg L À1 resveratrol [35] Saccharomyces cerevisiae Stilbeniod At4CL1, VvSTS HaTAL, Aro4(K229)L, Aro7 (G141S), Acc1(S659A,S1157A)
Mineral
Bioreactor 531.41 mg L À1 resveratrol [99] Saccharomyces cerevisiae
Stilbeniod
AtC4H, At4CL2, VvSTS AtATR2, CYB5, AtPAL2, ACC1 (S659A,S1157A), ARO7 (G141S), ARO4(K229L), 4aro10, SeACS(L641P)
Mineral
Bioreactor 800 mg L À1 resveratrol [51] Corynebacterium glutamicum [32] Escherichia coli Stilbeniod Nt4CK, VvSTS, AtROMT SeTAL, tyrA(fbr), aroG(fbr) M9 with met Flask 33.6 mg L À1 pterostilbene [100] Escherichia coli Stilbeniod PsSTS2(T248A), Sc4CL(A294G)
PcPAL1
Minimal, cerulenin Flask 70 mg L À1 pinosylvin [99] Saccharomyces cerevisiae Stilbeniod AtC4H, At4CL2, VvSTS, SbROMT AtATR2, CYB5, AtPAL2, ACC1 (S659A,S1157A), ARO7 (G141S), ARO4(K229L), 4aro10, SeACS(L641P) Minimal Flask 1.38 mg L À1 pinostilbene [99] Saccharomyces cerevisiae
Stilbeniod
AtC4H, At4CL2, VvSTS, VvROMT AtATR2, CYB5, AtPAL2, ACC1 (S659A,S1157A), ARO7 (G141S), ARO4(K229L), 4aro10, SeACS(L641P) Minimal Flask 5.52 mg L À1 pterostilbene [88] Escherichia coli Stilbeniod Sc4CL, AhSTS SeTAL Minimal Flask 1.4 mg L À1 resveratrol
For simplicity, strains that produce multiple products are entered by chemical class with specific products listed in the titer section. Heterologous genes with multiple potential origins are annotated with source organism initials as a prefix. Any mutations are described in parenthesis (fbr stands for feedback resistant), hyphens denote protein fusions.
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Polyphenols
As described above, polyphenol polyketides must interface with additional pathways in the cell as these molecules are synthesized using phenylpropanoid-derived CoA starters and malonyl-CoA extenders. There are three major classes of these molecules described in this section: flavonoids, stilbenoids, and curcuminoids. These main scaffold molecules can be further oxidized and modified downstream to produce an array of additional metabolites. These major reactions are outlined in Figure 4a .
Strategies for Precursor Production
None of the major microbial host systems commonly explored for polyketide production (as described in Section 2 above) natively produce phenylpropanoid CoA esters, thus precursor www.advancedsciencenews.com www.biotechnology-journal.com production and interfacing with host metabolism is required.
To do so, a precursor acid must be converted into the desired starter molecule via a downstream CoA ligase. The simplest approach is to directly feed the acid into the growth medium, typically cinnamic acid, 4-coumaric acid, or caffeic acid. This strategy can also enable downstream product diversification from the same strain by simply varying the medium conditions. [13, 47, 50, 51, [73] [74] [75] [76] [77] [78] For de novo production, cinnamic acid and 4-coumaric acid can be produced from amino acids through the introduction of phenylalanine amino lyase (PAL) and tyrosine amino lyase (TAL) enzymes, respectively. Often these enzymes have mixed activity, which also leads to a mixture of downstream products. [10, 25, 79] It should be noted that additional supplementation of tyrosine and phenylalanine is often necessary to achieve appreciable product levels. [10, 18, 25, 26, [79] [80] [81] [82] In order to improve higher de novo production, researchers have engineered tyrosine-rich strains of both E. coli [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] and S. cerevisiae [34] [35] [36] [37] with downstream CoA ligases. When combined with the desired type III PKSs and tailoring enzymes, the production of flavonoids, stilbenoids, and curcuminoids can be achieved in these hosts. We review progress in each of these three classes below.
Flavonoids
Flavonoids are an extremely broad class of plant metabolites that protect plants from pathogens, UV, and oxidative damage. [83, 84] Several chemicals in this group show potential as antioxidant protective agents and possess antitumor, antidiabetic, and neuroprotective activity. [85] [86] [87] Flavonoid molecules are produced from a phenylpropanoid CoA ester by the type III PKS, chalcone synthase (CHS) that catalyzes the extension into a chalcone. This starting flavonoid scaffold is then isomerized to produce a flavanone by chalcone isomerase (CHI) (Figure 4a ). Flavanone products include naringenin (from 4-coumaroyl-CoA), eridictol (from cinnamoyl-CoA), and pinocembrin (from caffeoyl-CoA). [13, 75, 76] When constructing a heterologous pathway for flavanone production, researchers have used 4-coumoryl-CoA ligase (4CL), CHS, and CHI sourced from a variety of different plants ( Table 1 ). The majority of these engineering efforts (regardless of host) yielded production in the tens of mg L À1 or lower. [10, 16, 24, 27, 47, 50, 73, [79] [80] [81] 88] Engineering strategies that increased the yields by an order of magnitude (to the hundreds of mg L À1 ) typically combined heterologous pathway integration with host optimization of malonyl-CoA content. [13, 15, 17, 28, 29, 76] Notably, a strain of E. coli engineered to overexpress ACC, phosphoglycerate kinase (PGK), and pyruvate dehydrogenase (PDH) was able to produce 474 mg L À1 naringenin on a flask fermentation scale when supplemented with 4-coumaric acid. [15] An alternative strategy that enhanced malonyl-CoA production through treatment with the fatty acid synthesis inhibitor cerulenin yielded 710 mg L À1 pinocembrin and 54 mg L À1 eriodictyol when fed the appropriate acid. [76] Significant improvements in naringenin production in S. cerevisiae were also achieved by replacing an essential enoylreductase with a plant homolog in order to prevent 4-coumoryl-CoA reduction. [13] The downstream modification and diversification of these products can be achieved through the activity of flavanone-3hydroxylase (F3H) and flavonol synthase (FLS) (Figure 4b ). This pathway yields kaempferol (from naringenin), resokaempferol (from liquiritigenin), [11, 37, 51, 89] and galangin (from pinocembrin). [11, 46] As a third step, additional flavonol products can be made through the activity of a flavonoid 3 0monooxygenase (FMO) together with a cytochrome P450 reductase (CPR) to yield quercetin (from naringenin), [37, 51] fisetin (from liquiritigenin), [37, 90] and catechin (from eriodictyol). [14] As described above, S. cerevisiae is able to more readily express these plant-derived CPRs; however, success has been achieved in E. coli through truncation and codonoptimization of these genes to improve solubility. [90] High levels of flavonol can be produced through direct supplementation of the upstream flavanone, evidencing the potential for future engineering to allow de novo production of these compounds. [14] Impressively, a S. cerevisiae strain optimized for tyrosine production was able to produce 26.7 mg L À1 of kaempferol and 20.38 mg L À1 quercetin without any precursor supplementation. [37] As an alternative to flavonol production, flavanones can also be oxidized to flavones such as chrysin (from pinocembrin), apigenin (from naringenin), and luteolin (from eriodictyol) through the activity of flavone synthases (FSI/FSII). [46, 74, 75] Additional modifications can also be added to flavanones: glycosylation yielding anthocynanins [76, 91, 92] or methylation, creating the medicinally promising compound 7-O-methylaromadendrin. [93] Collectively, these efforts demonstrated the potential to produce and diversify flavonoids in two major host organisms, but more work needs to be done to increase titers.
Stilbenoids
One of the most commonly studied and storied stilbene products is the antioxidant resveratrol. This chemical is produced by the type III PKS, stilbene synthase (STS), in combination with 4CL, adding three malonyl-CoA units to 4coumaroyl-CoA. [33] In this regard, resveratrol can be produced simply by the complementation of two enzymes into a host strain. [52, 78, 82, [94] [95] [96] As described with other polyketides above, resveratrol production can be enhanced through malonyl-CoA enrichment strategies. [18, 35, 40, 97] By importing 4CL and STS into an industrial sugar-cane fermenting strain of S. cerevisiae, researchers were able to achieve production of 391 mg L À1 when cultures were supplemented with 4-coumaric acid. [98] A higher titer resulted from a rationally engineered strain of S. cerevisiae, optimized for both malonyl-CoA and tyrosine production. Specifically, with the addition of a heterologous TAL, 4CL, and STS, this strain was able to produce 800 mg L À1 of resveratrol de novo without the need for supplementation. [99] A strain of E. coli engineered with a PAL to produce cinnamoyl-CoA instead of coumaroyl-CoA enabled the production of 70 mg L À1 of a different stilbene, pinosylvin from the same STS enzyme. [100] In a similar fashion to flavanones, additional stilbenoids can be produced through modification of resveratrol including mono-and di-methylation by resveratrol O-methylase (ROMT) enzymes to produce pinostilbene and pterostilbene respectively. [32, 47, 53, 77, 99, 101] 
Curcuminoids
A final, yet distinctive, class of polyphenolic polyketides produced by type III PKSs are curcuminoids. These interesting synthases use two phenylpropanoid CoA starters and a single malonyl-CoA to produce the resulting curcuminoid. In order for this chemistry to work properly, a diketide must be added to one of the CoA starters prior to condensation. Enzyme function is diverse within this class. [6] For example, the curcumin synthase (CURS) isolated from Curcuma longa requires an additional diketide synthase (DCS) to perform this reaction whereas the CURS isolated from Arabadopsis thaliana and the curcminoid synthase (CUS) from Oryza sativa perform both diketide and curcuminoid synthesis. Both strategies have been imported into microbial hosts to successfully yield curcuminoid production. [26, 31, 102] When combined with ACC overexpression in E. coli, the second strategy was able to produce 91 mg L À1 of the primary curcumin product, bisdemethoxycurcumin in acid supplemented flask fermentation. [103] As a more complex polyketide, the overall titer has been limited in this important class of bioactive compounds.
Future Prospects for Type III PKS-Derived Polyketide Engineering
Moving beyond heterologous pathway expression strategies and basic metabolic rewiring, there are additional evolutionary and computational tools that can be applied to polyketide engineering in order to further expand host potential.
Genetic Tools and Biosensors for Polyketide Metabolic Engineering
As outlined above, the majority of metabolic engineering strategies employed for increasing type III PKS-derived polyketide production used rational engineering methods. However, high throughput screening of mutant libraries, especially via biosensors, can be integral to the metabolic engineering design cycle. [104] To this end, the malonyl-CoA responsive Bacillus subtilis transcription factor, FapR has been imported into both S. cerevisiae and E. coli. [19] [20] [21] 43, 44] This malonyl-CoA sensor has been used to screen an overexpression library, yielding targets that improved titers of the malonyl-CoA derived production, 3-hydroxypropionic acid. [43] FapR-based systems have also been used to dynamically regulate pathway flux, further optimizing the production of malonyl-CoA-derived productions in these hosts. [19] [20] [21] 44] In addition to this transcription factor-based system, a recent study used the THN synthase, RppA, to detect malonyl-CoA colorimetrically by observing the red pigment flaviolin. [105] E. coli knockdowns identified using this system were found to promote increased production of several polyketide products, including the type III-derived chemicals aloesone, naringenin, and resveratrol. [105] Biosensors have also been developed that directly sense polyketide production. The E. coli regulator AraC has been engineered to activate gene expression in response to the presence of triacetic acid lactone, thus creating the biosensor AraC-TAL. [106] This triacetic acid lactone biosensor was employed to screen a library of g2ps1 mutants, selecting a variant that codes for a 2-PS with increased catalytic efficiency. [106] Excitingly, this biosensor was also used to screen a transposon library of insertions [62] and overexpressions, [63] to identify further E. coli host genetic modifications that increase production levels. The targets identified in this screen were found to be transferrable for other polyketides such as increased production of phloroglucinol when PhlD was imported into these mutant strains. [62] In a similar fashion, the TtgR regulatory protein was engineered to respond to the stilbene, resveratrol. [107] This biosensor was then used to screen a library of 4CL mutants, selecting variants that could also be applied to improve naringenin production. [107] The increase in high-throughput screening capacity through biosensors and other means will further enhance the ability to apply evolutionary metabolic engineering strategies and result in increased rates, titers, and yields.
Computational Tools for PKS Discovery and Characterization
An additional emerging area relevant to the production of polyketides and secondary metabolites more generally are computational tools used to identify novel pathways of interest. A recently developed, useful computational tool called anti-SMASH searches genomes for common features associated with biosynthetic gene clusters. [108] This tool can quickly narrow down the genome of poorly annotated organisms to identify putative, interesting clusters including PKSs. To search more specifically for type III PKSs, a computational tool called pPAP was developed specifically for plant PKSs that utilize phenylpropanoid CoA starters. [109] Given an amino acid sequence, the software will categorize the protein into one of four different reaction groups as well as predict the number of chain extensions and type of cyclization chemistry. This new tool can help further narrow down a list of target PKSs and help predict biochemistry rather than just crude PKS function homology.
Non-Natural Polyketide Products
Polyketide diversification via a type III mechanism is possible through both exploring new genes (and modifying enzymes) as well as exploiting the promiscuity of these enzymes. Specifically, researchers have developed biological systems for feeding unnatural carboxylic acids into polyketide producing strains and exploiting the PKS promiscuity. Katsuyama et al. employed E. coli strains with flavanone, stilbene, and flavonol synthesis pathways to produce a total of 87 polyketides simply by varying carboxylic acid conditions. [110] In a follow up study, they expanded this approach through the use of a curcuminoid production strain and produced 15 distinct curcuminoids. [111] Interestingly, asymmetric curcuminoid synthesis was achieved through the supplementation of two different precursors simultaneously. [111] This approach was further expanded to vary both starter and extender CoA precursors through the addition of phenylacetate CoA ligase, benzoyl CoA ligase, and methylmalonyl-CoA synthase activities. This final system was linked with a CHS enzyme to produce a diverse polyketide library that yielded two unique, bioactive molecules in a screen against Gram-and Gram-positive bacteria. [112] Upon analysis, one compound (bisnoryangonin) had previously been identified as a potential antimicrobial whereas the second (3,6,7-trihydroxy-2-(4-methoxybenzyl)-4H-1-benzopyran-4,5,8-trione) had not previously been identified. [112] Further applications of type III PKSs include an in vitro set up, where THN synthase, along with a peroxidase, generated a variety of truncated pyrones and pyrone couplings. [113] These initial efforts demonstrate the immense potential of PKSs to serve as catalysts well beyond their canonical reactions.
Conclusions
Both acyl-CoA-and phenylpropanoid-derived polyketides have been produced by microorganisms using a variety of engineering strategies. This exciting array of compounds have applications as biorenewable platform chemicals, pharmaceuticals, and nutraceuticals. However, the production of these molecules is often limited to less than the g L À1 level, requiring further engineering efforts. Specifically, most current polyketide metabolic engineering studies have been limited to heterologous pathway importation along with some strain engineering. The use of high-throughput screens can certainly boost yields and identify novel targets for increasing production. Likewise, expansion into promising, non-conventional hosts (such as seen from Y. lipolytica) holds promise for obtaining high titers of these important molecules. The rise in computational tools and demonstration of promiscuity indicates that further pathways can be identified, engineered, and evolved to produce a wider array of chemical building blocks in the future. 
